Can AI catch lung scarring that doctors might miss?

NCT ID NCT07761377

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study evaluates whether an AI software called AccuPulmo CT Portal can accurately detect pulmonary fibrosis, a type of lung scarring, on chest CT scans. Researchers will compare the AI's readings against assessments by three lung specialists using 900 past scans. The goal is to see how sensitive and specific the AI is at identifying fibrosis, which could lead to faster and more consistent diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AccuPulmo CT Portal, an AI-assisted medical imaging software that analyzes chest CT images to estimate the proportion of pulmonary fibrosis in the lung.
What this could lead to
If the AI proves accurate, it could help doctors spot pulmonary fibrosis earlier and more consistently on CT scans, potentially speeding up diagnosis and treatment planning.
What could go wrong
This is a retrospective study using existing images, not a real-world test. The AI may not perform as well in broader clinical settings, and its accuracy depends on the reference standard set by specialists.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taichung Veterans General Hospital City: Taichung

    RECRUITING

    Taichung, 407219, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.